These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 31154604)
21. Comparative Analysis of Biological and Functional Properties of Bone Marrow Mesenchymal Stromal Cells Expanded in Media with Different Platelet Lysate Content. Skific M; Golemovic M; Crkvenac-Gornik K; Vrhovac R; Golubic Cepulic B Cells Tissues Organs; 2018; 205(4):226-239. PubMed ID: 30223277 [TBL] [Abstract][Full Text] [Related]
22. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Gottipamula S; Sharma A; Krishnamurthy S; Majumdar AS; Seetharam RN Biotechnol Lett; 2012 Jul; 34(7):1367-74. PubMed ID: 22476583 [TBL] [Abstract][Full Text] [Related]
24. Rat marrow-derived mesenchymal stem cells developed in a medium supplemented with the autologous versus bovine serum. Eslaminejad MB; Rouhi L; Arabnajafi M; Baharvand H Cell Biol Int; 2009 May; 33(5):607-16. PubMed ID: 19286467 [TBL] [Abstract][Full Text] [Related]
25. Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study. Shaz BH; Schäfer R; Fontaine MJ; Norris PJ; McKenna DH; Jin P; Reems JA; Stroncek D; Tanashi M; Marks D; Geng H; Pati S; Cytotherapy; 2024 Jun; 26(6):531-539. PubMed ID: 38043052 [TBL] [Abstract][Full Text] [Related]
26. Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells. Pham PV; Vu NB; Pham VM; Truong NH; Pham TL; Dang LT; Nguyen TT; Bui AN; Phan NK J Transl Med; 2014 Feb; 12():56. PubMed ID: 24565047 [TBL] [Abstract][Full Text] [Related]
27. A double-virally-inactivated (Intercept-solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells. Barro L; Su YT; Nebie O; Wu YW; Huang YH; Koh MB; Knutson F; Burnouf T Transfusion; 2019 Jun; 59(6):2061-2073. PubMed ID: 30912158 [TBL] [Abstract][Full Text] [Related]
28. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design. Fan X; Liu T; Liu Y; Ma X; Cui Z Biotechnol Prog; 2009; 25(2):499-507. PubMed ID: 19319963 [TBL] [Abstract][Full Text] [Related]
29. The immunosuppressive mechanisms of mesenchymal stem cells are differentially regulated by platelet poor plasma and fetal bovine serum supplemented media. Silva-Carvalho AÉ; Neves FAR; Saldanha-Araujo F Int Immunopharmacol; 2020 Feb; 79():106172. PubMed ID: 31926480 [TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of in vitro proliferative, migratory and pro-angiogenic potentials of bovine fetal mesenchymal stem cells derived from bone marrow and adipose tissue. Jervis M; Huaman O; Cahuascanco B; Bahamonde J; Cortez J; Arias JI; Torres CG; Peralta OA Vet Res Commun; 2019 Aug; 43(3):165-178. PubMed ID: 31201618 [TBL] [Abstract][Full Text] [Related]
31. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Shahdadfar A; Frønsdal K; Haug T; Reinholt FP; Brinchmann JE Stem Cells; 2005 Oct; 23(9):1357-66. PubMed ID: 16081661 [TBL] [Abstract][Full Text] [Related]
32. Comparing the effect of using 2-Mercaptoethanol in the cell culture medium of different cell passages of human mesenchymal stem cells. Khasawneh RR; Abu-El-Rub E Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):35-39. PubMed ID: 38678630 [TBL] [Abstract][Full Text] [Related]
33. Effect of expansion media and fibronectin coating on growth and chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Basoli V; Della Bella E; Kubosch EJ; Alini M; Stoddart MJ Sci Rep; 2021 Jun; 11(1):13089. PubMed ID: 34158528 [TBL] [Abstract][Full Text] [Related]
34. Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience. Becherucci V; Piccini L; Casamassima S; Bisin S; Gori V; Gentile F; Ceccantini R; De Rienzo E; Bindi B; Pavan P; Cunial V; Allegro E; Ermini S; Brugnolo F; Astori G; Bambi F Stem Cell Res Ther; 2018 May; 9(1):124. PubMed ID: 29720245 [TBL] [Abstract][Full Text] [Related]
35. Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method. Moon GJ; Cho YH; Kim DH; Sung JH; Son JP; Kim S; Cha JM; Bang OY Cell Transplant; 2018 Mar; 27(3):485-500. PubMed ID: 29774769 [TBL] [Abstract][Full Text] [Related]
36. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Schallmoser K; Bartmann C; Rohde E; Reinisch A; Kashofer K; Stadelmeyer E; Drexler C; Lanzer G; Linkesch W; Strunk D Transfusion; 2007 Aug; 47(8):1436-46. PubMed ID: 17655588 [TBL] [Abstract][Full Text] [Related]
37. Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype. Clark KC; Kol A; Shahbenderian S; Granick JL; Walker NJ; Borjesson DL Stem Cell Rev Rep; 2016 Apr; 12(2):245-56. PubMed ID: 26638159 [TBL] [Abstract][Full Text] [Related]
38. Comparing the immunomodulatory properties of equine BM-MSCs culture expanded in autologous platelet lysate, pooled platelet lysate, equine serum and fetal bovine serum supplemented culture media. Even KM; Gaesser AM; Ciamillo SA; Linardi RL; Ortved KF Front Vet Sci; 2022; 9():958724. PubMed ID: 36090170 [TBL] [Abstract][Full Text] [Related]
39. Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro. Griffiths S; Baraniak PR; Copland IB; Nerem RM; McDevitt TC Cytotherapy; 2013 Dec; 15(12):1469-83. PubMed ID: 23981539 [TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Abdelrazik H; Spaggiari GM; Chiossone L; Moretta L Eur J Immunol; 2011 Nov; 41(11):3281-90. PubMed ID: 21874650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]